Robert H. Uhl
Investor Relations Contact chez DMK PHARMACEUTICALS CORPORATION
Profil
Robert H.
Uhl is currently a Managing Director at Westwicke Partners LLC since 2011 and also serves as an Investor Relations Contact at DMK Pharmaceuticals Corp.
Additionally, he worked as a Director-Investor Relations at Halozyme Therapeutics, Inc. in 2010.
Postes actifs de Robert H. Uhl
| Sociétés | Poste | Début |
|---|---|---|
| DMK PHARMACEUTICALS CORPORATION | Investor Relations Contact | - |
Westwicke Partners LLC
 Westwicke Partners LLC Investment ManagersFinance Westwicke Partners LLC operates as a strategic communications and advisory firm that is focused exclusively on healthcare. It offers digital branding, crisis communications, and capital markets advisory. The company was founded by Robert East and Mark Klausner in 2006 and is headquartered in Baltimore, MD. | Corporate Officer/Principal | 01/01/2011 |
Anciens postes connus de Robert H. Uhl
| Sociétés | Poste | Fin |
|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Investor Relations Contact | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| HALOZYME THERAPEUTICS, INC. | Health Technology |
| DMK PHARMACEUTICALS CORPORATION | Health Technology |
| Entreprise privées | 1 |
|---|---|
Westwicke Partners LLC
Westwicke Partners LLC Investment ManagersFinance Westwicke Partners LLC operates as a strategic communications and advisory firm that is focused exclusively on healthcare. It offers digital branding, crisis communications, and capital markets advisory. The company was founded by Robert East and Mark Klausner in 2006 and is headquartered in Baltimore, MD. | Finance |
